Publications Toxicology

Golka K, Schöps W:

Berufliche Exposition als Risikofaktor für Tumoren der harnableitenden Wege. UroForum 17(4): 26-30 (2026)

Böthig R, Golka K:

Neurogene Harnblase und Harnblasenkrebs – besondere Risiken bei Querschnittlähmung. UroForum 17(4): 26-30 (2026)

Hammour MM, Herzberger L, Xin Y, Chen G, Tombaz M, Ehnert S, Springer F, Damm G, Vosough M, Hengstler JG, Müller-Vieira U, Nüssler AK, Aspera-Werz RH:

Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver-bone model. Arch Toxicol (2026) doi: 10.1007/s00204-026-04431-x

Hernández AF, Jeddi MZ, Wilks MF, FitzGerald R, Duca RC, Villeneuve D, Viegas S, Hotta A, Baucher MA, Browne P, Scholten B, Simon E, Poddalgoda D, Bal-Price A, Mustieles V, van Thriel C, Bonassi S, Fenech M, Ndaw S, Pieper C, Rissler J, Paini A, Farcal L, Schmid K, Pasanen-Kase R, Hopf NB:

Using effect biomarker thresholds in regulatory risk assessment: an OECD-based framework for assessing cumulative exposures to chemical mixtures. Environ Int 211: 110215 (2026) doi: 10.1016/j.envint.2026.110215

Batke M, Damm G, Foth H, Freyberger A, Hengstler JG, Mangerich A, Mielke H, Partosch F, Schupp T, Sonnenburg A, Vom Brocke J, Wollin KM, Algharably EA, Gundert-Remy U:

A tool to assess the internal validity of toxicokinetic studies. Arch Toxicol 100: 2955–2965 (2026) doi: 10.1007/s00204-026-04387-y

van Kesteren PCE, van Berlo D, Bard D, Butler O, Dekkers S, Hadrup N, Lovén K, Riediker M, Schins RPF, van Thriel C, Vogel U, Gosens I:

Health-based nanomaterial guidance value (HNGV) for occupational exposure to spheroidal biodurable engineered nanomaterials of relatively low substance-specific toxicity. NanoImpact 42: 100621 (2026) doi: 10.1016/j.impact.2026.100621

Niegisch G, Gakis G, Ohlmann CH, Knüchel-Clarke R, Beyersdorff D, Rick O, Golka K, Hegemann M, Goebell PJ, Maisch P, Gschwend J:

Leitlinie „Harnblasenkarzinom“ – was gibt es Neues? [Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]. Urologie 65: 490–497 (2026) doi: 10.1007/s00120-026-02810-x

Adesida SO, Oyetunji RA, Alimba CG:

Bioactive Compounds from Edible Mushrooms as Pharmaceutical Ingredients: A Comprehensive Review of the Developmental Pipeline. Processes 14(5): 795 (2026) doi: 10.3390/pr14050795

Alwahsh M, Abusara OH, Zaid AA, Hasan A, Hamadneh L, Marchan R:

Synergistic cytotoxic effect of doxorubicin and bortezomib on lung cancer cell lines using 2D and 3D models. Cancer Treat Res Commun 47: 101133 (2026) doi: 10.1016/j.ctarc.2026.101133

Lampen A, Lachenmeier DW, Diel P, Ensenauer R, Frommherz L, Guth S, Humpf HU, Kulling SE, Villar-Fernández MA, Wätjen W, Mally A, Steinberg P:

Dietary phosphate exposure–strategies to protect vulnerable population groups. Arch Toxicol 100: 1657–1684 (2026) doi: 10.1007/s00204-025-04274-y